Copyright
©The Author(s) 2024.
World J Stem Cells. Dec 26, 2024; 16(12): 1012-1021
Published online Dec 26, 2024. doi: 10.4252/wjsc.v16.i12.1012
Published online Dec 26, 2024. doi: 10.4252/wjsc.v16.i12.1012
Figure 3 Ultrasonographic findings before and after cell therapy.
A: Resistive index at pretreatment and 6 months after cell therapy; B: Shear wave velocity at pretreatment and 6 months after cell therapy. Both intra-renal resistive index and shear wave velocity significantly improved at 6 months after 1st cell therapy compared to pretreatment values. aP < 0.05, bP < 0.01.
- Citation: Ohtake T, Sato T, Tsukiyama T, Muraoka S, Mitomo A, Maruyama H, Yamano M, Mochida Y, Ishioka K, Oka M, Moriya H, Hidaka S, Masuda H, Asahara T, Kobayashi S. Preliminary evidence of renal function improvement in chronic progressive kidney disease using autologous CD34+ cell therapy: A clinical trial. World J Stem Cells 2024; 16(12): 1012-1021
- URL: https://www.wjgnet.com/1948-0210/full/v16/i12/1012.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v16.i12.1012